Baidu
map

食药监总局通报“洋参龟灵口服液”等10起虚假宣传广告

2017-04-20 国家食品药品监督管理总局网站 国家食品药品监督管理总局网站

总局关于10起虚假宣传广告的通告(2017年第58号)2017年04月20日 发布近期,食品药品监管部门监测到4起药品、3起医疗器械和3起保健食品广告宣传内容存在含有不科学的功效断言、扩大宣传治愈率或有效率、利用患者名义或形象做功效证明等问题,欺骗和误导消费者,严重危害公众饮食用药安全。现将有关情况通告如下:一、贵阳济仁堂药业有限公司生产的处方药“疗癣卡西甫散”。该产品通过“金芙克官方网站暨网上商

总局关于10起虚假宣传广告的通告(2017年第58号)

2017年04月20日 发布

近期,食品药品监管部门监测到4起药品、3起医疗器械和3起保健食品广告宣传内容存在含有不科学的功效断言、扩大宣传治愈率或有效率、利用患者名义或形象做功效证明等问题,欺骗和误导消费者,严重危害公众饮食用药安全。现将有关情况通告如下:

一、贵阳济仁堂药业有限公司生产的处方药“疗癣卡西甫散”。该产品通过“金芙克官方网站暨网上商城”网站宣传,标识产品名称为“疗癣卡西甫散”,广告中宣称“早晚一碗黄金汤,30天顽癣全除光,坚持喝上一个月,顽癣一次从根断,确保20年不犯”等内容。

二、吉林省神经精神病医院制药厂生产的处方药“复方苯巴比妥溴化钠片”。该产品通过“药康网”网站宣传,标识产品名称为“复方苯巴比妥溴化钠片”,广告中宣称“6个月临床观察,96.7%患者语言、运动能力明显提高,有些轻度的患者已基本达到治愈”等内容。

三、昆明中药厂有限公司生产的处方药“癫痫宁片”。该产品通过“癫痫宁片厂价直销”网站宣传,标识产品名称为“癫痫宁片”,广告中宣称“治疗癫痫病起效迅速不复发,不论病程长短及不同病因,服用8至10天就有明显效果”等内容。

四、山东润华药业有限公司生产的处方药“洋参龟灵口服液”。该产品通过“智力健官网”网站宣传,标识产品名称为“洋参龟灵口服液”,广告中宣称“一个疗程孩子变得安静了,脾气也好了,平均有效率高达93.15%,三个月还你一个健康的宝宝”等内容。

五、郑州弘德堂健康产业有限公司生产的医疗器械“远红外贴”。该产品通过“丁氏骨康贴官网”网站宣传,标识产品名称为“远红外贴”,广告中宣称“颈椎增生床都下不了,是丁氏骨康贴让我又站了起来,不怕骨病重,越重越管用,97%的人使用一个月内症状明显改善或消失”等内容。

六、武汉健康新天地科技有限公司生产的医疗器械“烫熨治疗贴”。该产品通过“百年穆氏熨烫治疗贴官方官网”网站宣传,标识产品名称为“烫熨治疗贴”,广告中宣称“关节炎贴上就舒服,肩周炎不扎针更轻松,骨质增生肿痛有改善,痛经三个月后疼痛缓解”等内容。

七、武汉海纳川科技有限公司生产的医疗器械“半导体激光治疗仪”。该产品通过“鼻之光第三代官网”网站宣传,标识产品名称为“半导体激光治疗仪”,广告中宣称“当天见好,7天治愈,15天根除治愈咽炎,7天消除症状,30天断根不复发治愈鼻炎”等内容。

八、保健食品“轩生堂牌四怀糖脂安胶囊”的证件持有人为郑州轩生堂药业有限公司。该产品通过“神农本草降糖官网”网站宣传,标识产品名称为“轩生堂牌四怀糖脂安胶囊”,广告中宣称“服用25天,血糖平稳下降,服用50天,血糖得到控制,服用75天,胰岛功能改善,血液中垃圾堵塞得到清除”等内容。

九、保健食品“红润牌真采口服液”的证件持有人为中山市美太保健制品有限公司。该产品通过“润美巢羊胎素口服液官方网站”网站宣传,标识产品名称为“红润牌真采口服液”,广告中宣称“7天明显感觉精力旺盛,10天缓解女性更年期症状,40天月经周期规律,肢体麻木等症状消除”等内容。

十、保健食品“京仁堂牌人参海狗丸”的证件持有人为江门市蓬江区京仁堂生物科技有限公司。该产品通过“人参海狗丸官网”网站宣传,标识产品名称为“京仁堂牌人参海狗丸”,广告中宣称“7至10天头晕等症状明显改善,1个月扫除阳痿、早泄等性功能障碍烦恼,2个月促进性功能二次发育”等内容。

对上述违法广告和网站,食品药品监管部门已将其违法行为移送有关部门查处。有关省级食品药品监管部门要依法撤销其有效期内的广告批准文号。各省(区、市)食品药品监管部门要认真履行属地监管责任,加大对违法广告的跟踪监测工作力度,一经发现,要依法采取撤销广告批准文号、责令产品暂停销售等措施,移送有关部门对广告违法行为严肃查处,并向社会公开处理结果。对涉嫌销售假劣产品的,应依法立案查处,涉嫌犯罪的,移送公安机关追究刑事责任。

特此通告。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2076209, encodeId=811e20e6209cd, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Jul 15 13:21:00 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672354, encodeId=dbc816e2354e1, content=<a href='/topic/show?id=95c58850418' target=_blank style='color:#2F92EE;'>#虚假#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88504, encryptionId=95c58850418, topicName=虚假)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ab626907756, createdName=doctor-chen9591, createdTime=Thu Aug 31 07:21:00 CST 2017, time=2017-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1981151, encodeId=48ab1981151b4, content=<a href='/topic/show?id=1bbe38225a4' target=_blank style='color:#2F92EE;'>#口服液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38225, encryptionId=1bbe38225a4, topicName=口服液)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=856b247, createdName=songbq, createdTime=Wed Dec 13 06:21:00 CST 2017, time=2017-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840411, encodeId=6dc218404114e, content=<a href='/topic/show?id=186b8e937c6' target=_blank style='color:#2F92EE;'>#药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87937, encryptionId=186b8e937c6, topicName=药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sat Mar 10 17:21:00 CST 2018, time=2018-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705861, encodeId=f09c1e058612c, content=<a href='/topic/show?id=76e510114468' target=_blank style='color:#2F92EE;'>#食药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101144, encryptionId=76e510114468, topicName=食药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a73b31099952, createdName=lilili1114, createdTime=Thu Jan 11 07:21:00 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=189201, encodeId=dd07189201cf, content=严打, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8732047543, createdName=wen2009, createdTime=Fri Apr 21 00:23:52 CST 2017, time=2017-04-21, status=1, ipAttribution=)]
    2017-07-15 cmsvly
  2. [GetPortalCommentsPageByObjectIdResponse(id=2076209, encodeId=811e20e6209cd, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Jul 15 13:21:00 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672354, encodeId=dbc816e2354e1, content=<a href='/topic/show?id=95c58850418' target=_blank style='color:#2F92EE;'>#虚假#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88504, encryptionId=95c58850418, topicName=虚假)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ab626907756, createdName=doctor-chen9591, createdTime=Thu Aug 31 07:21:00 CST 2017, time=2017-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1981151, encodeId=48ab1981151b4, content=<a href='/topic/show?id=1bbe38225a4' target=_blank style='color:#2F92EE;'>#口服液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38225, encryptionId=1bbe38225a4, topicName=口服液)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=856b247, createdName=songbq, createdTime=Wed Dec 13 06:21:00 CST 2017, time=2017-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840411, encodeId=6dc218404114e, content=<a href='/topic/show?id=186b8e937c6' target=_blank style='color:#2F92EE;'>#药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87937, encryptionId=186b8e937c6, topicName=药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sat Mar 10 17:21:00 CST 2018, time=2018-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705861, encodeId=f09c1e058612c, content=<a href='/topic/show?id=76e510114468' target=_blank style='color:#2F92EE;'>#食药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101144, encryptionId=76e510114468, topicName=食药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a73b31099952, createdName=lilili1114, createdTime=Thu Jan 11 07:21:00 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=189201, encodeId=dd07189201cf, content=严打, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8732047543, createdName=wen2009, createdTime=Fri Apr 21 00:23:52 CST 2017, time=2017-04-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2076209, encodeId=811e20e6209cd, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Jul 15 13:21:00 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672354, encodeId=dbc816e2354e1, content=<a href='/topic/show?id=95c58850418' target=_blank style='color:#2F92EE;'>#虚假#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88504, encryptionId=95c58850418, topicName=虚假)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ab626907756, createdName=doctor-chen9591, createdTime=Thu Aug 31 07:21:00 CST 2017, time=2017-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1981151, encodeId=48ab1981151b4, content=<a href='/topic/show?id=1bbe38225a4' target=_blank style='color:#2F92EE;'>#口服液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38225, encryptionId=1bbe38225a4, topicName=口服液)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=856b247, createdName=songbq, createdTime=Wed Dec 13 06:21:00 CST 2017, time=2017-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840411, encodeId=6dc218404114e, content=<a href='/topic/show?id=186b8e937c6' target=_blank style='color:#2F92EE;'>#药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87937, encryptionId=186b8e937c6, topicName=药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sat Mar 10 17:21:00 CST 2018, time=2018-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705861, encodeId=f09c1e058612c, content=<a href='/topic/show?id=76e510114468' target=_blank style='color:#2F92EE;'>#食药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101144, encryptionId=76e510114468, topicName=食药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a73b31099952, createdName=lilili1114, createdTime=Thu Jan 11 07:21:00 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=189201, encodeId=dd07189201cf, content=严打, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8732047543, createdName=wen2009, createdTime=Fri Apr 21 00:23:52 CST 2017, time=2017-04-21, status=1, ipAttribution=)]
    2017-12-13 songbq
  4. [GetPortalCommentsPageByObjectIdResponse(id=2076209, encodeId=811e20e6209cd, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Jul 15 13:21:00 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672354, encodeId=dbc816e2354e1, content=<a href='/topic/show?id=95c58850418' target=_blank style='color:#2F92EE;'>#虚假#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88504, encryptionId=95c58850418, topicName=虚假)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ab626907756, createdName=doctor-chen9591, createdTime=Thu Aug 31 07:21:00 CST 2017, time=2017-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1981151, encodeId=48ab1981151b4, content=<a href='/topic/show?id=1bbe38225a4' target=_blank style='color:#2F92EE;'>#口服液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38225, encryptionId=1bbe38225a4, topicName=口服液)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=856b247, createdName=songbq, createdTime=Wed Dec 13 06:21:00 CST 2017, time=2017-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840411, encodeId=6dc218404114e, content=<a href='/topic/show?id=186b8e937c6' target=_blank style='color:#2F92EE;'>#药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87937, encryptionId=186b8e937c6, topicName=药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sat Mar 10 17:21:00 CST 2018, time=2018-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705861, encodeId=f09c1e058612c, content=<a href='/topic/show?id=76e510114468' target=_blank style='color:#2F92EE;'>#食药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101144, encryptionId=76e510114468, topicName=食药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a73b31099952, createdName=lilili1114, createdTime=Thu Jan 11 07:21:00 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=189201, encodeId=dd07189201cf, content=严打, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8732047543, createdName=wen2009, createdTime=Fri Apr 21 00:23:52 CST 2017, time=2017-04-21, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2076209, encodeId=811e20e6209cd, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Jul 15 13:21:00 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672354, encodeId=dbc816e2354e1, content=<a href='/topic/show?id=95c58850418' target=_blank style='color:#2F92EE;'>#虚假#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88504, encryptionId=95c58850418, topicName=虚假)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ab626907756, createdName=doctor-chen9591, createdTime=Thu Aug 31 07:21:00 CST 2017, time=2017-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1981151, encodeId=48ab1981151b4, content=<a href='/topic/show?id=1bbe38225a4' target=_blank style='color:#2F92EE;'>#口服液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38225, encryptionId=1bbe38225a4, topicName=口服液)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=856b247, createdName=songbq, createdTime=Wed Dec 13 06:21:00 CST 2017, time=2017-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840411, encodeId=6dc218404114e, content=<a href='/topic/show?id=186b8e937c6' target=_blank style='color:#2F92EE;'>#药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87937, encryptionId=186b8e937c6, topicName=药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sat Mar 10 17:21:00 CST 2018, time=2018-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705861, encodeId=f09c1e058612c, content=<a href='/topic/show?id=76e510114468' target=_blank style='color:#2F92EE;'>#食药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101144, encryptionId=76e510114468, topicName=食药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a73b31099952, createdName=lilili1114, createdTime=Thu Jan 11 07:21:00 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=189201, encodeId=dd07189201cf, content=严打, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8732047543, createdName=wen2009, createdTime=Fri Apr 21 00:23:52 CST 2017, time=2017-04-21, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2076209, encodeId=811e20e6209cd, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Jul 15 13:21:00 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672354, encodeId=dbc816e2354e1, content=<a href='/topic/show?id=95c58850418' target=_blank style='color:#2F92EE;'>#虚假#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88504, encryptionId=95c58850418, topicName=虚假)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ab626907756, createdName=doctor-chen9591, createdTime=Thu Aug 31 07:21:00 CST 2017, time=2017-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1981151, encodeId=48ab1981151b4, content=<a href='/topic/show?id=1bbe38225a4' target=_blank style='color:#2F92EE;'>#口服液#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38225, encryptionId=1bbe38225a4, topicName=口服液)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=856b247, createdName=songbq, createdTime=Wed Dec 13 06:21:00 CST 2017, time=2017-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840411, encodeId=6dc218404114e, content=<a href='/topic/show?id=186b8e937c6' target=_blank style='color:#2F92EE;'>#药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87937, encryptionId=186b8e937c6, topicName=药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sat Mar 10 17:21:00 CST 2018, time=2018-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1705861, encodeId=f09c1e058612c, content=<a href='/topic/show?id=76e510114468' target=_blank style='color:#2F92EE;'>#食药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101144, encryptionId=76e510114468, topicName=食药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a73b31099952, createdName=lilili1114, createdTime=Thu Jan 11 07:21:00 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=189201, encodeId=dd07189201cf, content=严打, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8732047543, createdName=wen2009, createdTime=Fri Apr 21 00:23:52 CST 2017, time=2017-04-21, status=1, ipAttribution=)]
    2017-04-21 wen2009

    严打

    0

相关资讯

食品药品监督管理总局曝光8起虚假宣传广告

国家食品药品监督管理总局9月3日通告,近期,食品药品监管部门监测到4个药品和4个保健食品擅自发布含有夸大宣传治愈率或有效率,利用患者的名义、形象做功效证明和承诺等问题的虚假广告,欺骗和误导消费者。具体通告情况如下:一、违法广告所涉企业及产品情况:(一)西安大唐制药集团有限公司生产的药品“醒脾开胃颗粒(广告中标示名称:大唐奥舒)”。该产品通过电视媒介发布违法广告,宣称“大唐奥舒用了效果就是不一样,一

Baidu
map
Baidu
map
Baidu
map